LBMC recently announced Ann S. Brandt, PhD, as director of the firm's new Life Sciences Valuation and Consulting service line within the company's national healthcare practice. Brandt brings more than 25 years of healthcare experience to her role leading the new service line, which leverages existing LBMC resources to provide a full range of valuation and consulting services to life science companies, with a focus on pharmaceutical, medical device, and biotechnology companies.

Prior to joining LBMC, Brandt was partner at a large healthcare valuation company where she developed and managed multiple services including a global life sciences service line. A frequent speaker, she has authored multiple articles and book chapters.